http://www.vaccinesafety.edu/thi-table.htm
Thimerosal
Content in Some US Licensed Vaccines
updated
6-20-2000
| Vaccine | Brand Name | Manufacturer |
|
Mercury ug/0.5 ml | pg in 2000 PDR | pg in 1999 PDR |
|---|---|---|---|---|---|---|
| Anthrax | Anthrax vaccine | BioPort Corporation |
|
|
||
| DTaP
|
Acel-Imune
Tripedia Certiva Infanrix |
Lederle
Laboratories
Pasteur Merieux Connaught North American Vaccine SmithKline Beecham |
.01% .01% 0 |
25 25 0 |
2307 1986 3010 |
2340 1972 3061 |
| DTwP | All Products |
|
|
|||
| DT | All Products |
|
|
|||
| Td | All Products |
|
|
|||
| TT | All Products |
|
|
|||
| DTwP-Hib | Tetramune | Lederle Laboratories |
|
|
|
|
| Hib | ActHIB
ProHIBiT(4) TriHIBit HibTITER multi-dose single dose PedvaxHIB liquid(2) COMVAX(3) Omni HIB |
Pasteur
Merieux Connaught
Pasteur Merieux Connaught Pasteur Merieux Connaught Lederle Laboratories Lederle Laboratories Merck Merck SmithKline Beecham |
.01% .01% .01% 0 0 0 0 |
25 25 25 0 0 0 0 |
- - 1531 1531 1850 1760 3022 |
2345 2340 1520 1520 1853 1750 3072 |
| Hepatitis A | Havrix
Vaqta adult/pediatric |
SmithKline
Beecham
Merck |
0 |
0 |
1899 |
1906 |
| Hepatitis B | Engerix-B
Engerix-B preservative free Recombivax HB Recombivax HB preservative free |
SmithKline
Beecham
SmithKline Beecham Merck Merck |
-- .005% 0 |
.05* 12.5 0 |
-- 1880 1880 |
-- -- 1883 |
| Influenza | All products |
|
|
|||
| IPV | IPOL | Pasteur Merieux Connaught |
|
|
|
|
| Lyme | LYMErix | SmithKline Beecham |
|
|
|
|
| Meningococcal | Menomune A, C, AC and A/C/Y/W-135 | CLI |
|
|
|
|
| MMR | MMR-II | Merck |
|
|
|
|
| OPV | Orimune | Lederle Laboratories |
|
|
|
|
| Pneumococcal |
Pnu-Imune 23 Pneumovax 23 |
Wyeth-Lederle
Vaccines
Lederle Laboratories Merck |
.01% 0 |
25 0 |
1541 1858 |
1533 1860 |
| Rabies
|
Rabies
Vaccine Adsorbed
RabAvert IMOVAX |
Bioport
Corporation
Chiron Pasteur Merieux Connaught |
0 0 |
0 0 |
941 2296 |
898 2329 |
| Rotavirus | Rotashield | Wyeth-Ayerst |
|
|
|
|
| Typhoid | Vivotef Ty21a | Berna |
|
|
|
|
| Typhoid Fever | Typhim
Vi
Typhoid vaccine |
Pasteur
Merieux Connaught
Wyeth-Ayerst |
0 |
0 |
3336 |
3399 |
| Varicella | Varivax | Merck |
|
|
|
|
| Yellow Fever | YF-Vax | Pasteur Merieux Connaught |
|
|
|
1. A concentration of 1:10,000 is equivalent to a 0.01% concentration. Thimerosal is approximately 50% Hg by weight. A 1:10,000 concentration contains 25 micrograms of Hg per 0.5 mL.
2. A previously marketed lyophilized preparation contained .05% thimerosal.
3. COMVAX is not approved for use under 6 weeks of age because of decreased response to the Hib component.
4. ProHIBit is recommended by the Academy only for children 12 months of age and older.
*. The new Engerix-B product contains only trace amounts of thimerosal (<1 mcg)